EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Diabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer

Rui Yan, Patiguli Yisilamu, Yang Ge, Weiwei Zhou iD

Thoracic Cancer · 2026

DOI: 10.1111/1759-7714.70378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2026. Verfasst von Rui Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Chao-Yang Hospital Department of Oncology, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Diabetes Mellitus, Type 2. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (DM) is implicated in cancer development and associated with poor survival in patients with cancer. However, the impact of DM on the outcome of small cell lung cancer (SCLC) remains unknown. This study investigated the correlation between DM and clinical outcomes and long‐term prognosis of patients with extensive‐stage small cell lung cancer (ES‐SCLC).

Methods

This retrospective cohort study was conducted using the medical records of patients with ES‐SCLC treated with immune checkpoint inhibitors (ICIs) and chemotherapy. The demographic and clinical characteristics were retrospectively analyzed. Univariate and multivariate analyses were performed using Cox proportional hazards regression to evaluate the impact of the clinical characteristics on survival. Progression‐free survival (PFS) and overall survival (OS) were compared between patients with or without DM.

Results

Of the 91 patients with ES‐SCLC, 32 were diagnosed with DM before ES‐SCLC (35.2%). Patients with DM had significantly shorter median PFS (6 vs. 15 months, p = 0.026) and median OS (12 vs. 22 months, p = 0.013) than those without diabetes, despite receiving comparable chemoimmunotherapy. Multivariate cox regression analysis showed that DM was an independent risk factor for shorter mOS (HR 2.05, 95% CI 1.02–4.13, p = 0.044).

Conclusions

Patients with ES‐SCLC and comorbid diabetes exhibited significantly shorter OS and PFS compared with those without diabetes. DM serves as an independent adverse prognostic risk factor for ES‐SCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsDiabetes Mellitus, Type 2HumansFemalePrognosisMaleRetrospective StudiesRisk FactorsAgedMiddle Aged

Stichwörter der Autor:innen

ES‐SCLCchemotherapydiabetes mellitusimmune checkpoint inhibitors

Autor:innen und Institutionen

  • Beijing Chao-Yang Hospital Department of Oncology, Capital Medical University, Beijing, China.

ORCID-Profile: Weiwei Zhou

Zitieren

APA

Yan, R., Yisilamu, P., Ge, Y., & Zhou, W. (2026). Diabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70378

Vancouver

Yan R, Yisilamu P, Ge Y, Zhou W. Diabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer. Thoracic Cancer. 2026. doi:10.1111/1759-7714.70378

BibTeX
@article{Yan2026,
  author = {Yan, Rui and Yisilamu, Patiguli and Ge, Yang and Zhou, Weiwei},
  title = {Diabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer},
  journal = {Thoracic Cancer},
  year = {2026},
  doi = {10.1111/1759-7714.70378}
}
Kostenlos starten →